These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 30719766)

  • 1. C1qTNF-related protein-6 protects against doxorubicin-induced cardiac injury.
    Zheng WF; Zhang SY; Ma HF; Chang XW; Wang H
    J Cell Biochem; 2019 Jun; 120(6):10748-10755. PubMed ID: 30719766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1qTNF-related protein 1 attenuates doxorubicin-induced cardiac injury via activation of AKT.
    Chen H; Gao L; Huang Z; Liu Y; Guo S; Xing J; Meng Z; Liang C; Li Y; Yao R; Li L; Zhang Y; Gu H; Liu Y
    Life Sci; 2018 Aug; 207():492-498. PubMed ID: 29964055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrogen sulfide protects H9c2 cardiac cells against doxorubicin-induced cytotoxicity through the PI3K/Akt/FoxO3a pathway.
    Liu MH; Zhang Y; He J; Tan TP; Wu SJ; Guo DM; He H; Peng J; Tang ZH; Jiang ZS
    Int J Mol Med; 2016 Jun; 37(6):1661-8. PubMed ID: 27081862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-451 Silencing Inhibited Doxorubicin Exposure-Induced Cardiotoxicity in Mice.
    Li J; Wan W; Chen T; Tong S; Jiang X; Liu W
    Biomed Res Int; 2019; 2019():1528278. PubMed ID: 31355248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asiatic Acid Protects against Doxorubicin-Induced Cardiotoxicity in Mice.
    Hu X; Li B; Li L; Li B; Luo J; Shen B
    Oxid Med Cell Longev; 2020; 2020():5347204. PubMed ID: 32509145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA FOXC2-AS1 protects cardiomyocytes from doxorubicin-induced cardiotoxicity through activation of WNT1-inducible signaling pathway protein-1.
    Zhang S; Yuan Y; Zhang Z; Guo J; Li J; Zhao K; Qin Y; Qiu C
    Biosci Biotechnol Biochem; 2019 Apr; 83(4):653-658. PubMed ID: 30558506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
    Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
    Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT.
    Zhang X; Hu C; Kong CY; Song P; Wu HM; Xu SC; Yuan YP; Deng W; Ma ZG; Tang QZ
    Cell Death Differ; 2020 Feb; 27(2):540-555. PubMed ID: 31209361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible involvement of downregulation of the apelin-APJ system in doxorubicin-induced cardiotoxicity.
    Hamada J; Baasanjav A; Ono N; Murata K; Kako K; Ishida J; Fukamizu A
    Am J Physiol Heart Circ Physiol; 2015 Apr; 308(8):H931-41. PubMed ID: 25681427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against Doxorubicin-Related Cardiotoxicity by Jaceosidin Involves the Sirt1 Signaling Pathway.
    Liu Y; Zhou L; Du B; Liu Y; Xing J; Guo S; Li L; Chen H
    Oxid Med Cell Longev; 2021; 2021():9984330. PubMed ID: 34422218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin.
    Wang Y; Zheng D; Wei M; Ma J; Yu Y; Chen R; Lacefield JC; Xu H; Peng T
    Cardiovasc Res; 2013 Jun; 98(3):381-90. PubMed ID: 23455548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy.
    van Almen GC; Swinnen M; Carai P; Verhesen W; Cleutjens JP; D'hooge J; Verheyen FK; Pinto YM; Schroen B; Carmeliet P; Heymans S
    J Mol Cell Cardiol; 2011 Sep; 51(3):318-28. PubMed ID: 21624372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mulberrin Confers Protection against Doxorubicin-Induced Cardiotoxicity via Regulating AKT Signaling Pathways in Mice.
    Ye P; Li WL; Bao LT; Ke W
    Oxid Med Cell Longev; 2022; 2022():2967142. PubMed ID: 35847586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tirzepatide protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress and inflammation via PI3K/Akt signaling.
    Chen L; Chen X; Ruan B; Yang H; Yu Y
    Peptides; 2024 Aug; 178():171245. PubMed ID: 38801993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat shock protein 20 interacting with phosphorylated Akt reduces doxorubicin-triggered oxidative stress and cardiotoxicity.
    Fan GC; Zhou X; Wang X; Song G; Qian J; Nicolaou P; Chen G; Ren X; Kranias EG
    Circ Res; 2008 Nov; 103(11):1270-9. PubMed ID: 18948619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic clues to the protective effect of chrysin against doxorubicin-induced cardiomyopathy: Plausible roles of p53, MAPK and AKT pathways.
    Mantawy EM; Esmat A; El-Bakly WM; Salah ElDin RA; El-Demerdash E
    Sci Rep; 2017 Jul; 7(1):4795. PubMed ID: 28684738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astragalus polysaccharide restores autophagic flux and improves cardiomyocyte function in doxorubicin-induced cardiotoxicity.
    Cao Y; Shen T; Huang X; Lin Y; Chen B; Pang J; Li G; Wang Q; Zohrabian S; Duan C; Ruan Y; Man Y; Wang S; Li J
    Oncotarget; 2017 Jan; 8(3):4837-4848. PubMed ID: 27902477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMPK/PGC1α activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis.
    Liu D; Ma Z; Di S; Yang Y; Yang J; Xu L; Reiter RJ; Qiao S; Yuan J
    Free Radic Biol Med; 2018 Dec; 129():59-72. PubMed ID: 30172748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte.
    Wan GX; Cheng L; Qin HL; Zhang YZ; Wang LY; Zhang YG
    Cardiovasc Toxicol; 2019 Jun; 19(3):264-275. PubMed ID: 30535663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT/mTOR signaling.
    Zhang J; Wang M; Ding W; Zhao M; Ye J; Xu Y; Wang Z; Ye D; Li D; Liu J; Wan J
    Biochem Pharmacol; 2020 Oct; 180():114188. PubMed ID: 32750329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.